Jobs
-
At its January 29, 2013 meeting, the FDA’s Pulmonary-Allergy Drugs Advisory Committee (PADAC) recommended approval of the 5 µg dose of Boehringer Ingelheim’s Striverdi Respima olodaterol soft mist inhaler for the maintenance treatment of COPD.… Read more . . .
-
The UK’s National Institute for Health and Clinical Excellence (NICE) has issued a qualified recommendation for Forest Lab’s Colobreath colistimethate sodium and Novartis’s TOBI Podhaler tobramycin dry powders for inhalation as options for the treatment… Read more . . .
-
On January 22, 2013, the FDA published its final cGMP rule for combination products in the Federal Register. According to the rule’s summary, “This rule is intended to promote the public health by clarifying which… Read more . . .
-
According to Meda, the EU has approved the company’s Dymista azelastine/fluticasone nasal spray for the treatment of seasonal and perennial allergic rhinitis. Meda submitted an MAA for the product in late 2011. The company announced… Read more . . .
-
Allergan will acquire Levadex inhaled dihydroergotamine developer MAP Pharmaceuticals for $25 per share. The two companies entered into an agreement to co-promote Levadex in January 2011, and MAP submitted an NDA for the product later… Read more . . .
-
Powder characterization specialist Freeman Technology has named ATS Scientific Inc. as the Canadian distributor of the company’s FT4 Powder Rheometer. The powder rheometer generates data that can be used for optimization of aerosolization in dry… Read more . . .
-
Pearl Therapeutics, which is developing several inhaled drugs, has announced that it has hired Michael Riebe as VP, Pharmaceutical Development and Research, effective immediately. Riebe, a past chair and current steering committee member of the… Read more . . .
-
Unigene Laboratories has issued a statement in response to an FDA announcement of an upcoming advisory committee meeting scheduled for March 5, 2013 to discuss whether the benefits of calcitonin salmon outweigh the risk. The… Read more . . .
-
The FDA’s Pulmonary-Allergy Drugs Advisory Committee has scheduled discussion of a number of new drug applications for inhalation products in the next few months. The meetings are open to the public and will be available… Read more . . .
-
The client is an international pharmaceutical company based in Ireland looking to recruit for an Analytical Development Supervisor. For the role you must have a relevant third level science qualification and strong experience working with… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland